Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wulf

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Leukemia|May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trialGerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Bone Marrow Transplantation|November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.
Leukemia|January 19, 2017
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemiaR F Schlenk, P Frech, D Weber, et al.
Blood Cancer Journal|May 27, 2017
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemiaS Jaramillo, A Benner, J Krauter, et al.
Blood|January 17, 2016
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the diseaseBjoern Chapuy, Hongwei Cheng, Akira Watahiki, et al.
Bone Marrow Transplantation|January 22, 2019
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)W Wiktor-Jedrzejczak, J Drozd-Sokolowska, D J Eikema, et al.
Annals of Hematology|November 2, 2017
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)Gabriele Nagel, D Weber, E Fromm, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Leukemia|May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trialGerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Bone Marrow Transplantation|November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.
Leukemia|January 19, 2017
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemiaR F Schlenk, P Frech, D Weber, et al.
Blood Cancer Journal|May 27, 2017
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemiaS Jaramillo, A Benner, J Krauter, et al.
Blood|January 17, 2016
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the diseaseBjoern Chapuy, Hongwei Cheng, Akira Watahiki, et al.
Bone Marrow Transplantation|January 22, 2019
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)W Wiktor-Jedrzejczak, J Drozd-Sokolowska, D J Eikema, et al.
Annals of Hematology|November 2, 2017
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)Gabriele Nagel, D Weber, E Fromm, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Pageof 18